Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-09

FDA Approved: SEYSARA — Supplemental Application (Almirall, LLC)

View source ↗

Summary

The FDA has approved a supplemental application for SEYSARA (sarecycline hydrochloride) from Almirall, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Seysara (sarecycline)

Snippet

SUPPL AP for SEYSARA (SARECYCLINE HYDROCHLORIDE)